Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Bladder cancer, somatic (KRAS) MVZ Dr. Eberhard & Partner Dortmund Germany | 7 | 1 |
|
Hypertrophic Cardiomyopathy NGS Panel Fulgent Genetics United States | 375 | 86 |
|
Cardio-Facio-Cutaneous Syndrome NGS Panel Fulgent Genetics United States | 20 | 6 |
|
Somatic Overgrowth Panel with interpretation Clinical Genomics Laboratory Washington University in St. Louis United States | 86 | 49 |
|
Athena Diagnostics United States | 1 | 1 |
|
KRAS/RAF1/SOS1 DNA Sequencing Evaluation Athena Diagnostics United States | 3 | 3 |
|
Invitae Cardio-Facio-Cutaneous Syndrome Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 6 | 6 |
|
Fulgent Genetics United States | 9 | 1 |
|
Autoimmune Lymphoproliferative Syndrome Panel by next-generation sequencing (NGS) Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center United States | 14 | 15 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center United States | 42 | 31 |
|
Fulgent Genetics United States | 24 | 11 |
|
Genome Diagnostics Laboratory University Medical Center Utrecht Netherlands | 17 | 12 |
|
Intellectual Disability NGS Panel Fulgent Genetics United States | 1058 | 554 |
|
Congenital heart defects panel Genome Diagnostics Laboratory University Medical Center Utrecht Netherlands | 69 | 34 |
|
Noonan Syndrome Sequential Panel FirmaLab United States | 1 | 4 |
|
Cardiofaciocutaneous Syndrome Panel FirmaLab United States | 1 | 3 |
|
Comprehensive Cardiovascular NGS Panel Fulgent Genetics United States | 696 | 250 |
|
Praxis fuer Humangenetik Wien Austria | 1 | 1 |
|
Praxis fuer Humangenetik Wien Austria | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.